Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed And Ortho Firms Look To Chinese Market As Alternative To Japan’s

This article was originally published in The Gray Sheet

Executive Summary

As frustrations mount with Japan's device regulatory and reimbursement agencies, manufacturers who are looking to gain a foothold in the growing Asian market could transfer resources to China, AdvaMed CEO Steve Ubl said
Advertisement

Related Content

BSD Medical Plans To File PMA For Cancer Therapy, Prepares Japanese Strategy
BSD Medical Plans To File PMA For Cancer Therapy, Prepares Japanese Strategy
AdvaMed President Ubl Sets Ambitious FDA Performance, International Goals
AdvaMed President Ubl Sets Ambitious FDA Performance, International Goals
Chilly Japanese Medical Device Climate Draws Fire From Hill, Industry
Advertisement
UsernamePublicRestriction

Register

MT022824

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel